Format

Send to

Choose Destination
Pediatrics. 2020 Jan;145(1). pii: e20193448. doi: 10.1542/peds.2019-3448. Epub 2019 Dec 16.

Executive Summary: Identification, Evaluation, and Management of Children With Autism Spectrum Disorder.

Author information

1
Golisano Children's Hospital, University of Rochester, Rochester, New York; susan_hyman@RMC.Rochester.edu.
2
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and.
3
Geisinger Autism & Developmental Medicine Institute, Danville, Pennsylvania.
PMID:
31843858
DOI:
10.1542/peds.2019-3448

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: MeMix LLC is a company that makes an app (for phones). Dr Levy is on the advisory board for the app’s development. This app is being developed to assist in nutritional and dietary management of children with autism. Dr Levy has not received any money yet from this company. This app is the focus of a National Institutes of Health R21 grant, for which Dr Levy is funded for ∼2% of her salary. Once it is studied and marketed (if appropriate), Dr Levy will (possibly in the future) earn some money. Dr Levy has worked with MeMix LLC from 2015 to the present. Dr Hyman is the site principal investigator of a clinical trial of a novel agent being tested to promote social function in patients with autism. The University of Rochester (Dr Hyman’s institution) was 1 of >40 sites and had 2 study participants in 2018. University of Rochester will be leaving the trial in 2019 (withdrawal submitted) because of staffing, and that reimbursement for staff time does not cover the cost of participation. Funding was for the staff to complete the assessments required for the clinical trial. Dr Hyman got no personal reimbursement from the company; the funding was for staff time for recruitment and assessment and clinical research center support for the trial. Dr Myers has indicated he has no potential conflicts of interest to disclose.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center